ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,768Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 229

$762K Total Retail Price of All Prescriptions

Rank: 20 out of 229

542 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 542 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

14% of this provider’s 542 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 8,621 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 477 401 1 1
LISINOPRIL 399 361 2 2
SIMVASTATIN 338 266 3 3
HYDROCODONE-ACETAMINOPHEN 285 227 S3 4 7
AMLODIPINE BESYLATE 260 223 5 5
FUROSEMIDE 238 169 6 8
METOPROLOL TARTRATE 204 186 7 13
OMEPRAZOLE 165 121 8 4
GABAPENTIN 157 98 9 10
CITALOPRAM HBR 157 139 9 21
METOPROLOL SUCCINATE 153 152 11 16
OXYCODONE HCL 133 49 S2 12 37
METFORMIN HCL 132 111 13 6
PRAVASTATIN SODIUM 126 117 14 25
MORPHINE SULFATE ER 123 29 S2 15 70
NAMENDA 121 121 16 39
TAMSULOSIN HCL 118 97 17 24
FLUTICASONE PROPIONATE 113 96 18 23
LOSARTAN POTASSIUM 113 100 18 12
HYDROCHLOROTHIAZIDE 108 104 20 9
CARVEDILOL 104 98 21 31
FAMOTIDINE 104 73 21 84
ZOLPIDEM TARTRATE 103 85 23 20
WARFARIN SODIUM 98 91 24 17
LANTUS 98 66 24 40
MELOXICAM 96 64 26 45
LEVOXYL 94 93 27 148
SERTRALINE HCL 89 62 28 22
FLUOXETINE HCL 81 52 29 41
QUETIAPINE FUMARATE 80 80 30 90
RANITIDINE HCL 79 58 31 32
CLONIDINE HCL 77 50 32 69
DONEPEZIL HCL 75 61 33 29
DIOVAN 74 74 34 42
NEXIUM 71 66 35 48
CIPROFLOXACIN HCL 70 57 36 58
ATORVASTATIN CALCIUM 69 67 37 15
CLOPIDOGREL 67 62 38 44
ATENOLOL 67 51 38 19
OXYCODONE-ACETAMINOPHEN 66 59 S2 40 43
VESICARE 65 53 41 225
LACTULOSE 64 22 42 66
ALENDRONATE SODIUM 62 59 43 14
PROAIR HFA 58 48 44 38
TRAMADOL HCL 58 53 44 26
PHENYTOIN SODIUM EXTENDED 58 45 44 136
LEVEMIR 56 55 47 126
SPIRONOLACTONE 55 49 48 56
DOXEPIN HCL 55 43 48 228
LOVASTATIN 55 55 48 11
CRESTOR 54 49 51 30
ALLOPURINOL 53 48 52 27
PREDNISONE 51 41 53 35
GLIPIZIDE 51 45 53 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 20, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.